Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
Currier, Jeffrey R., Ngauy, Viseth, de Souza, Mark S., Ratto-Kim, Silvia, Cox, Josephine H., Polonis, Victoria R., Earl, Patricia, Moss, Bernard, Peel, Sheila, Slike, Bonnie, Sriplienchan, Somchai, ThVolume:
5
Langue:
english
Journal:
PLoS ONE
DOI:
10.1371/journal.pone.0013983
Date:
November, 2010
Fichier:
PDF, 756 KB
english, 2010